Heart failure (HF) has been recognized as a common complication of diabetes, with a
prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data …

In the last years, major progress occurred in heart failure (HF) management. Quadruple
therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst …

Heart failure (HF) is a major health care burden increasing in prevalence over time.
Effective, evidence-based interventions for HF prevention and management are needed to …

Many countries are facing the advent of super-aging societies, where sarcopenia and frailty
will become pertinent problems. The prevalence of comorbidities is a major problem in …

Complementary and alternative medicines (CAM) are commonly used across the world by
diverse populations and ethnicities but remain largely unregulated. Although many CAM …

Ketone bodies, the main one being β-hydroxybutyrate, have emerged as important
regulators of the cardiovascular system. In healthy individuals, as well as in individuals with …

Aims The aim of this study was to compare the diagnostic performance of the nutritional
indicators, the mini nutritional assessment‐short form (MNA‐SF), the geriatric nutritional risk …

Aims This study aimed to review meta‐analyses of randomised controlled trials that
evaluated the effectiveness of the Mediterranean Diet for the primary and secondary …

Heart failure (HF) is a complex clinical syndrome, associated with high rates of mortality,
hospitalization, and impairment of quality of life. Obesity and type 2 diabetes are major …

Vitamin D emerged as an important prognostic biomarker in heart failure (HF), with currently
highly debated therapeutic implications. Several trials on vitamin D supplementation in HF …